A detailed history of Mjp Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mjp Associates Inc holds 15,506 shares of PFE stock, worth $425,794. This represents 0.09% of its overall portfolio holdings.

Number of Shares
15,506
Previous 16,142 3.94%
Holding current value
$425,794
Previous $447,000 3.13%
% of portfolio
0.09%
Previous 0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$25.26 - $29.6 $16,065 - $18,825
-636 Reduced 3.94%
15,506 $433,000
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $59,158 - $67,933
2,285 Added 16.49%
16,142 $447,000
Q4 2023

Jan 18, 2024

BUY
$26.13 - $33.94 $124,091 - $161,181
4,749 Added 52.14%
13,857 $398,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $345,866 - $404,282
-10,778 Reduced 54.2%
9,108 $302,000
Q2 2023

Jul 11, 2023

SELL
$36.12 - $41.79 $65,377 - $75,639
-1,810 Reduced 8.34%
19,886 $729,000
Q1 2023

Apr 17, 2023

SELL
$39.39 - $51.28 $20,167 - $26,255
-512 Reduced 2.31%
21,696 $885,000
Q4 2022

Jan 20, 2023

BUY
$41.75 - $54.5 $44,881 - $58,587
1,075 Added 5.09%
22,208 $0
Q3 2022

Oct 12, 2022

SELL
$43.76 - $53.42 $49,580 - $60,524
-1,133 Reduced 5.09%
21,133 $925,000
Q2 2022

Jul 11, 2022

BUY
$46.53 - $55.17 $111,951 - $132,739
2,406 Added 12.11%
22,266 $1.17 Million
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $18,391 - $22,789
402 Added 2.07%
19,860 $1.03 Million
Q4 2021

Jan 18, 2022

BUY
$41.32 - $61.25 $127,926 - $189,630
3,096 Added 18.92%
19,458 $1.1 Million
Q3 2021

Oct 13, 2021

BUY
$39.25 - $50.42 $12,128 - $15,579
309 Added 1.92%
16,362 $704,000
Q2 2021

Jul 14, 2021

BUY
$35.91 - $40.68 $60,221 - $68,220
1,677 Added 11.67%
16,053 $629,000
Q1 2021

May 04, 2021

BUY
$33.49 - $37.77 $46,919 - $52,915
1,401 Added 10.8%
14,376 $521,000
Q4 2020

Jan 27, 2021

BUY
$33.47 - $42.56 $434,273 - $552,216
12,975 New
12,975 $478,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mjp Associates Inc Portfolio

Follow Mjp Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mjp Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mjp Associates Inc with notifications on news.